Novel papaverine-based mitochondrial complex i inhibitor smv-32 alleviates tumor hypoxia and radiosensitizes hypoxic tumors

Novel papaverine-based mitochondrial complex i inhibitor smv-32 alleviates tumor hypoxia and radiosensitizes hypoxic tumors

Novel papaverine-based mitochondrial complex i inhibitor smv-32 alleviates tumor hypoxia and radiosensitizes hypoxic tumors 1241 1755 Metabolism & Cancer

Martin Benej

Download PDF
Email
The ATPase inhibitor protein IF1 in cancer cells exposed to anoxia mimicking condition favors survival and proliferation of re-oxygenated cells
Loss of SDHB, but not SDHD, promotes dysregulated oxidative stress and vulnerability to ascorbate
The role of adipocyte G0/G1 Switch Gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes
Mitochondrial complex I null cancer models reveal unspecific antiproliferative effects of complex I inhibitors – Copie
Enter your
text here
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.